Share Price and Basic Stock Data
Last Updated: January 28, 2026, 4:06 pm
| PEG Ratio | -3.36 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Oriental Aromatics Ltd operates in the chemicals sector, specializing in organic compounds. As of the latest reporting period, the company’s share price stood at ₹255, with a market capitalization of ₹855 Cr. Over the past several quarters, the company has demonstrated varied sales performance. For instance, sales in September 2022 were ₹220.76 Cr, which rose to ₹226.82 Cr by September 2023. However, sales did experience a dip in the March 2023 quarter, where they recorded ₹195.34 Cr. The trailing twelve months (TTM) sales have reached ₹973 Cr, indicating a robust growth trajectory despite some fluctuations. The total sales for FY 2025 are reported at ₹935 Cr, slightly up from ₹854 Cr in FY 2023. This indicates an overall positive trend in revenue generation, reflecting the company’s resilience in navigating market challenges.
Profitability and Efficiency Metrics
Oriental Aromatics Ltd has faced challenges in profitability, reflected in its operating profit margin (OPM), which stood at 6.35%. The company reported an operating profit of ₹94 Cr for FY 2025, a recovery from ₹54 Cr in FY 2023. However, net profit has fluctuated significantly, with a reported net profit of ₹34 Cr for FY 2025, up from ₹20 Cr in FY 2023. The return on equity (ROE) is relatively low at 5.31%, indicating potential inefficiencies in capital utilization compared to industry norms. The interest coverage ratio (ICR) at 3.81x suggests that the company is adequately covering its interest obligations, although the declining trend in OPM raises concerns about cost management. Overall, while the company has made strides in recovering profitability, it still faces challenges in sustaining high margins.
Balance Sheet Strength and Financial Ratios
The balance sheet of Oriental Aromatics Ltd shows a mixed picture of financial health. As of the latest report, total assets stood at ₹1,145 Cr, with total liabilities of ₹1,193 Cr, indicating a slight over-leverage situation. The company’s borrowings rose to ₹398 Cr, increasing from ₹231 Cr in FY 2023, which raises concerns about financial stability. The debt-to-equity ratio is reported at 0.53x, which is reasonable but reflects increased reliance on debt financing. Reserves have grown to ₹645 Cr, providing a buffer against potential downturns. The price-to-book value (P/BV) ratio is at 1.40x, which is lower than the typical sector range, indicating that the stock may be undervalued. Additionally, the current ratio of 1.68x suggests adequate short-term liquidity, although the quick ratio of 0.71x indicates potential challenges in meeting immediate obligations without selling inventory.
Shareholding Pattern and Investor Confidence
Oriental Aromatics Ltd has a stable shareholding structure, with promoters holding a significant 74.17% stake, demonstrating strong management control and commitment to the company. The public holds 25.81% of shares, while foreign institutional investors (FIIs) and domestic institutional investors (DIIs) have minimal involvement, at 0.03% and 0.00%, respectively. This limited institutional participation reflects a potential risk for liquidity and market perception, as the stock is largely driven by retail investor sentiment. The number of shareholders has shown a decline, with 25,734 shareholders reported as of September 2025, indicating a shrinking retail base. This could affect the stock’s volatility and overall market appeal. The stable promoter stake, however, suggests that management is aligned with shareholder interests, which can bolster investor confidence in the company’s long-term strategies.
Outlook, Risks, and Final Insight
Looking ahead, Oriental Aromatics Ltd faces both opportunities and risks. The company’s ability to improve its profitability metrics, particularly OPM, will be crucial for attracting investor interest and ensuring sustainable growth. The rising debt levels pose a significant risk, especially in an environment of increasing interest rates, which could pressure margins further. The company’s reliance on a concentrated promoter holding may also limit market dynamics, making it vulnerable to shifts in investor sentiment. Conversely, the growth in sales and reserves positions the company well to navigate challenges. If the company can leverage its operational strengths and enhance cost efficiency, it may unlock further value for shareholders. However, failure to address profitability concerns and manage debt effectively could hinder growth prospects and investor sentiment.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujchem Distillers India Ltd | 56.7 Cr. | 159 | 437/135 | 132 | 392 | 0.06 % | 0.21 % | 0.09 % | 1.00 |
| Elantas Beck India Ltd | 7,278 Cr. | 9,180 | 14,250/8,150 | 52.7 | 1,177 | 0.08 % | 23.0 % | 17.4 % | 10.0 |
| Crestchem Ltd | 27.4 Cr. | 91.2 | 329/84.1 | 13.6 | 26.9 | 1.10 % | 59.9 % | 44.1 % | 10.0 |
| Chemiesynth (Vapi) Ltd | 11.6 Cr. | 37.6 | 37.6/35.8 | 32.8 | 0.00 % | 3.10 % | 0.99 % | 10.0 | |
| ARCL Organics Ltd | 204 Cr. | 255 | 435/163 | 11.3 | 108 | 0.00 % | 20.4 % | 16.8 % | 10.0 |
| Industry Average | 4,502.92 Cr | 1,456.91 | 56.05 | 334.84 | 0.43% | 14.71% | 10.69% | 7.56 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 220.76 | 199.42 | 195.34 | 195.69 | 226.82 | 197.41 | 216.48 | 215.76 | 236.77 | 222.57 | 253.16 | 225.52 | 271.33 |
| Expenses | 206.19 | 185.39 | 186.16 | 194.76 | 215.81 | 183.30 | 195.60 | 193.65 | 208.15 | 200.02 | 233.89 | 207.46 | 254.09 |
| Operating Profit | 14.57 | 14.03 | 9.18 | 0.93 | 11.01 | 14.11 | 20.88 | 22.11 | 28.62 | 22.55 | 19.27 | 18.06 | 17.24 |
| OPM % | 6.60% | 7.04% | 4.70% | 0.48% | 4.85% | 7.15% | 9.65% | 10.25% | 12.09% | 10.13% | 7.61% | 8.01% | 6.35% |
| Other Income | 2.35 | 0.61 | 0.74 | 0.57 | 2.81 | 2.16 | 1.74 | 1.69 | 2.10 | 0.09 | 0.24 | 0.27 | 3.00 |
| Interest | 3.32 | 4.16 | 3.15 | 4.60 | 5.46 | 6.87 | 3.43 | 4.06 | 6.34 | 6.36 | 8.62 | 8.07 | 9.72 |
| Depreciation | 4.81 | 4.98 | 4.97 | 4.81 | 4.94 | 4.96 | 5.08 | 4.89 | 5.16 | 6.40 | 7.23 | 7.70 | 7.81 |
| Profit before tax | 8.79 | 5.50 | 1.80 | -7.91 | 3.42 | 4.44 | 14.11 | 14.85 | 19.22 | 9.88 | 3.66 | 2.56 | 2.71 |
| Tax % | 27.99% | 30.91% | 33.89% | -23.64% | 29.24% | 41.22% | 28.28% | 26.13% | 23.10% | 27.73% | 60.93% | 80.47% | 73.06% |
| Net Profit | 6.34 | 3.80 | 1.19 | -6.05 | 2.42 | 2.61 | 10.12 | 10.98 | 14.78 | 7.14 | 1.42 | 0.50 | 0.74 |
| EPS in Rs | 1.88 | 1.13 | 0.35 | -1.80 | 0.72 | 0.78 | 3.01 | 3.26 | 4.39 | 2.12 | 0.42 | 0.15 | 0.22 |
Last Updated: December 29, 2025, 5:33 pm
Below is a detailed analysis of the quarterly data for Oriental Aromatics Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 271.33 Cr.. The value appears strong and on an upward trend. It has increased from 225.52 Cr. (Jun 2025) to 271.33 Cr., marking an increase of 45.81 Cr..
- For Expenses, as of Sep 2025, the value is 254.09 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 207.46 Cr. (Jun 2025) to 254.09 Cr., marking an increase of 46.63 Cr..
- For Operating Profit, as of Sep 2025, the value is 17.24 Cr.. The value appears to be declining and may need further review. It has decreased from 18.06 Cr. (Jun 2025) to 17.24 Cr., marking a decrease of 0.82 Cr..
- For OPM %, as of Sep 2025, the value is 6.35%. The value appears to be declining and may need further review. It has decreased from 8.01% (Jun 2025) to 6.35%, marking a decrease of 1.66%.
- For Other Income, as of Sep 2025, the value is 3.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.27 Cr. (Jun 2025) to 3.00 Cr., marking an increase of 2.73 Cr..
- For Interest, as of Sep 2025, the value is 9.72 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 8.07 Cr. (Jun 2025) to 9.72 Cr., marking an increase of 1.65 Cr..
- For Depreciation, as of Sep 2025, the value is 7.81 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7.70 Cr. (Jun 2025) to 7.81 Cr., marking an increase of 0.11 Cr..
- For Profit before tax, as of Sep 2025, the value is 2.71 Cr.. The value appears strong and on an upward trend. It has increased from 2.56 Cr. (Jun 2025) to 2.71 Cr., marking an increase of 0.15 Cr..
- For Tax %, as of Sep 2025, the value is 73.06%. The value appears to be improving (decreasing) as expected. It has decreased from 80.47% (Jun 2025) to 73.06%, marking a decrease of 7.41%.
- For Net Profit, as of Sep 2025, the value is 0.74 Cr.. The value appears strong and on an upward trend. It has increased from 0.50 Cr. (Jun 2025) to 0.74 Cr., marking an increase of 0.24 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.22. The value appears strong and on an upward trend. It has increased from 0.15 (Jun 2025) to 0.22, marking an increase of 0.07.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:51 am
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 458 | 506 | 755 | 760 | 709 | 873 | 854 | 842 | 935 | 973 |
| Expenses | 400 | 441 | 639 | 633 | 553 | 780 | 799 | 795 | 841 | 895 |
| Operating Profit | 57 | 65 | 116 | 127 | 156 | 93 | 54 | 47 | 94 | 77 |
| OPM % | 13% | 13% | 15% | 17% | 22% | 11% | 6% | 6% | 10% | 8% |
| Other Income | 6 | -0 | -2 | 7 | 1 | 4 | 6 | 7 | 3 | 4 |
| Interest | 5 | 7 | 13 | 12 | 2 | 4 | 13 | 20 | 25 | 33 |
| Depreciation | 14 | 15 | 18 | 19 | 17 | 17 | 19 | 20 | 24 | 29 |
| Profit before tax | 44 | 43 | 83 | 103 | 137 | 76 | 27 | 14 | 48 | 19 |
| Tax % | 37% | 42% | 31% | 16% | 26% | 30% | 28% | 35% | 28% | |
| Net Profit | 28 | 25 | 57 | 86 | 102 | 53 | 20 | 9 | 34 | 10 |
| EPS in Rs | 13.54 | 7.43 | 16.98 | 25.61 | 30.29 | 15.84 | 5.87 | 2.70 | 10.20 | 2.91 |
| Dividend Payout % | 3% | 7% | 6% | 10% | 8% | 9% | 9% | 18% | 5% |
YoY Net Profit Growth
| Year | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -10.71% | 128.00% | 50.88% | 18.60% | -48.04% | -62.26% | -55.00% | 277.78% |
| Change in YoY Net Profit Growth (%) | 0.00% | 138.71% | -77.12% | -32.27% | -66.64% | -14.22% | 7.26% | 332.78% |
Oriental Aromatics Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 8 years from 2017-2018 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 4% |
| 3 Years: | 2% |
| TTM: | 10% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -17% |
| 3 Years: | -14% |
| TTM: | -9% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 1% |
| 3 Years: | -12% |
| 1 Year: | -33% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 7% |
| 3 Years: | 3% |
| Last Year: | 5% |
Last Updated: September 5, 2025, 12:00 pm
Balance Sheet
Last Updated: December 4, 2025, 1:45 am
| Month | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 8 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 |
| Reserves | 311 | 329 | 375 | 447 | 540 | 588 | 608 | 616 | 646 | 645 |
| Borrowings | 105 | 132 | 183 | 51 | 78 | 140 | 231 | 206 | 353 | 398 |
| Other Liabilities | 69 | 103 | 98 | 93 | 110 | 120 | 130 | 157 | 129 | 133 |
| Total Liabilities | 490 | 573 | 673 | 608 | 745 | 865 | 986 | 995 | 1,145 | 1,193 |
| Fixed Assets | 211 | 212 | 245 | 236 | 236 | 265 | 273 | 270 | 480 | 467 |
| CWIP | 15 | 40 | 1 | 2 | 13 | 25 | 53 | 173 | 5 | 7 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 264 | 321 | 428 | 370 | 496 | 574 | 661 | 551 | 660 | 720 |
| Total Assets | 490 | 573 | 673 | 608 | 745 | 865 | 986 | 995 | 1,145 | 1,193 |
Below is a detailed analysis of the balance sheet data for Oriental Aromatics Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 17.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 17.00 Cr..
- For Reserves, as of Sep 2025, the value is 645.00 Cr.. The value appears to be declining and may need further review. It has decreased from 646.00 Cr. (Mar 2025) to 645.00 Cr., marking a decrease of 1.00 Cr..
- For Borrowings, as of Sep 2025, the value is 398.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 353.00 Cr. (Mar 2025) to 398.00 Cr., marking an increase of 45.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 133.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 129.00 Cr. (Mar 2025) to 133.00 Cr., marking an increase of 4.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,193.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,145.00 Cr. (Mar 2025) to 1,193.00 Cr., marking an increase of 48.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 467.00 Cr.. The value appears to be declining and may need further review. It has decreased from 480.00 Cr. (Mar 2025) to 467.00 Cr., marking a decrease of 13.00 Cr..
- For CWIP, as of Sep 2025, the value is 7.00 Cr.. The value appears strong and on an upward trend. It has increased from 5.00 Cr. (Mar 2025) to 7.00 Cr., marking an increase of 2.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 720.00 Cr.. The value appears strong and on an upward trend. It has increased from 660.00 Cr. (Mar 2025) to 720.00 Cr., marking an increase of 60.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,193.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,145.00 Cr. (Mar 2025) to 1,193.00 Cr., marking an increase of 48.00 Cr..
Notably, the Reserves (645.00 Cr.) exceed the Borrowings (398.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -48.00 | -67.00 | -67.00 | 76.00 | 78.00 | -47.00 | -177.00 | -159.00 | -259.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 80 | 97 | 77 | 73 | 97 | 81 | 81 | 78 | 74 |
| Inventory Days | 141 | 148 | 149 | 124 | 211 | 183 | 233 | 177 | 238 |
| Days Payable | 41 | 68 | 39 | 43 | 66 | 52 | 55 | 52 | 50 |
| Cash Conversion Cycle | 180 | 177 | 187 | 154 | 242 | 213 | 259 | 203 | 262 |
| Working Capital Days | 117 | 90 | 87 | 109 | 154 | 151 | 139 | 99 | 95 |
| ROCE % | 11% | 19% | 21% | 24% | 12% | 5% | 4% | 8% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| PGIM India Small Cap Fund | 190,192 | 0.46 | 6.71 | 190,192 | 2025-04-22 15:56:55 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Basic EPS (Rs.) | 10.20 | 2.71 | 5.87 | 15.84 | 30.29 |
| Diluted EPS (Rs.) | 10.20 | 2.71 | 5.87 | 15.84 | 30.29 |
| Cash EPS (Rs.) | 17.24 | 8.59 | 11.64 | 20.89 | 35.48 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 197.00 | 187.90 | 185.70 | 179.84 | 165.59 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 197.00 | 187.90 | 185.70 | 179.84 | 165.59 |
| Revenue From Operations / Share (Rs.) | 275.83 | 248.53 | 252.30 | 258.16 | 210.63 |
| PBDIT / Share (Rs.) | 28.72 | 16.11 | 17.81 | 28.80 | 46.57 |
| PBIT / Share (Rs.) | 21.69 | 10.23 | 12.04 | 23.75 | 41.38 |
| PBT / Share (Rs.) | 14.15 | 4.18 | 8.17 | 22.55 | 40.70 |
| Net Profit / Share (Rs.) | 10.20 | 2.71 | 5.87 | 15.84 | 30.29 |
| NP After MI And SOA / Share (Rs.) | 10.20 | 2.71 | 5.87 | 15.84 | 30.29 |
| PBDIT Margin (%) | 10.41 | 6.48 | 7.05 | 11.15 | 22.11 |
| PBIT Margin (%) | 7.86 | 4.11 | 4.77 | 9.19 | 19.64 |
| PBT Margin (%) | 5.12 | 1.68 | 3.23 | 8.73 | 19.32 |
| Net Profit Margin (%) | 3.69 | 1.08 | 2.32 | 6.13 | 14.38 |
| NP After MI And SOA Margin (%) | 3.69 | 1.08 | 2.32 | 6.13 | 14.38 |
| Return on Networth / Equity (%) | 5.17 | 1.43 | 3.15 | 8.80 | 18.29 |
| Return on Capital Employeed (%) | 9.48 | 4.80 | 5.88 | 11.76 | 23.74 |
| Return On Assets (%) | 2.99 | 0.91 | 2.00 | 6.16 | 13.68 |
| Long Term Debt / Equity (X) | 0.11 | 0.08 | 0.05 | 0.07 | 0.00 |
| Total Debt / Equity (X) | 0.53 | 0.32 | 0.36 | 0.23 | 0.13 |
| Asset Turnover Ratio (%) | 0.86 | 0.84 | 0.91 | 1.08 | 1.05 |
| Current Ratio (X) | 1.68 | 1.90 | 2.15 | 2.99 | 3.02 |
| Quick Ratio (X) | 0.71 | 0.90 | 0.91 | 1.45 | 1.58 |
| Inventory Turnover Ratio (X) | 2.89 | 1.65 | 1.93 | 2.39 | 2.13 |
| Dividend Payout Ratio (NP) (%) | 4.90 | 18.48 | 0.00 | 9.47 | 8.25 |
| Dividend Payout Ratio (CP) (%) | 2.90 | 5.82 | 0.00 | 7.17 | 7.04 |
| Earning Retention Ratio (%) | 95.10 | 81.52 | 0.00 | 90.53 | 91.75 |
| Cash Earning Retention Ratio (%) | 97.10 | 94.18 | 0.00 | 92.83 | 92.96 |
| Interest Coverage Ratio (X) | 3.81 | 2.66 | 4.60 | 23.96 | 67.83 |
| Interest Coverage Ratio (Post Tax) (X) | 2.35 | 1.45 | 2.52 | 14.18 | 45.12 |
| Enterprise Value (Cr.) | 1267.80 | 1198.42 | 1395.23 | 2504.87 | 2032.54 |
| EV / Net Operating Revenue (X) | 1.37 | 1.43 | 1.64 | 2.88 | 2.87 |
| EV / EBITDA (X) | 13.12 | 22.10 | 23.28 | 25.84 | 12.97 |
| MarketCap / Net Operating Revenue (X) | 0.99 | 1.20 | 1.39 | 2.73 | 2.79 |
| Retention Ratios (%) | 95.09 | 81.51 | 0.00 | 90.52 | 91.74 |
| Price / BV (X) | 1.40 | 1.59 | 1.89 | 3.92 | 3.54 |
| Price / Net Operating Revenue (X) | 0.99 | 1.20 | 1.39 | 2.73 | 2.79 |
| EarningsYield | 0.03 | 0.01 | 0.01 | 0.02 | 0.05 |
After reviewing the key financial ratios for Oriental Aromatics Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 10.20. This value is within the healthy range. It has increased from 2.71 (Mar 24) to 10.20, marking an increase of 7.49.
- For Diluted EPS (Rs.), as of Mar 25, the value is 10.20. This value is within the healthy range. It has increased from 2.71 (Mar 24) to 10.20, marking an increase of 7.49.
- For Cash EPS (Rs.), as of Mar 25, the value is 17.24. This value is within the healthy range. It has increased from 8.59 (Mar 24) to 17.24, marking an increase of 8.65.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 197.00. It has increased from 187.90 (Mar 24) to 197.00, marking an increase of 9.10.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 197.00. It has increased from 187.90 (Mar 24) to 197.00, marking an increase of 9.10.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 275.83. It has increased from 248.53 (Mar 24) to 275.83, marking an increase of 27.30.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 28.72. This value is within the healthy range. It has increased from 16.11 (Mar 24) to 28.72, marking an increase of 12.61.
- For PBIT / Share (Rs.), as of Mar 25, the value is 21.69. This value is within the healthy range. It has increased from 10.23 (Mar 24) to 21.69, marking an increase of 11.46.
- For PBT / Share (Rs.), as of Mar 25, the value is 14.15. This value is within the healthy range. It has increased from 4.18 (Mar 24) to 14.15, marking an increase of 9.97.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 10.20. This value is within the healthy range. It has increased from 2.71 (Mar 24) to 10.20, marking an increase of 7.49.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 10.20. This value is within the healthy range. It has increased from 2.71 (Mar 24) to 10.20, marking an increase of 7.49.
- For PBDIT Margin (%), as of Mar 25, the value is 10.41. This value is within the healthy range. It has increased from 6.48 (Mar 24) to 10.41, marking an increase of 3.93.
- For PBIT Margin (%), as of Mar 25, the value is 7.86. This value is below the healthy minimum of 10. It has increased from 4.11 (Mar 24) to 7.86, marking an increase of 3.75.
- For PBT Margin (%), as of Mar 25, the value is 5.12. This value is below the healthy minimum of 10. It has increased from 1.68 (Mar 24) to 5.12, marking an increase of 3.44.
- For Net Profit Margin (%), as of Mar 25, the value is 3.69. This value is below the healthy minimum of 5. It has increased from 1.08 (Mar 24) to 3.69, marking an increase of 2.61.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 3.69. This value is below the healthy minimum of 8. It has increased from 1.08 (Mar 24) to 3.69, marking an increase of 2.61.
- For Return on Networth / Equity (%), as of Mar 25, the value is 5.17. This value is below the healthy minimum of 15. It has increased from 1.43 (Mar 24) to 5.17, marking an increase of 3.74.
- For Return on Capital Employeed (%), as of Mar 25, the value is 9.48. This value is below the healthy minimum of 10. It has increased from 4.80 (Mar 24) to 9.48, marking an increase of 4.68.
- For Return On Assets (%), as of Mar 25, the value is 2.99. This value is below the healthy minimum of 5. It has increased from 0.91 (Mar 24) to 2.99, marking an increase of 2.08.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.11. This value is below the healthy minimum of 0.2. It has increased from 0.08 (Mar 24) to 0.11, marking an increase of 0.03.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.53. This value is within the healthy range. It has increased from 0.32 (Mar 24) to 0.53, marking an increase of 0.21.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.86. It has increased from 0.84 (Mar 24) to 0.86, marking an increase of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 1.68. This value is within the healthy range. It has decreased from 1.90 (Mar 24) to 1.68, marking a decrease of 0.22.
- For Quick Ratio (X), as of Mar 25, the value is 0.71. This value is below the healthy minimum of 1. It has decreased from 0.90 (Mar 24) to 0.71, marking a decrease of 0.19.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.89. This value is below the healthy minimum of 4. It has increased from 1.65 (Mar 24) to 2.89, marking an increase of 1.24.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 4.90. This value is below the healthy minimum of 20. It has decreased from 18.48 (Mar 24) to 4.90, marking a decrease of 13.58.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 2.90. This value is below the healthy minimum of 20. It has decreased from 5.82 (Mar 24) to 2.90, marking a decrease of 2.92.
- For Earning Retention Ratio (%), as of Mar 25, the value is 95.10. This value exceeds the healthy maximum of 70. It has increased from 81.52 (Mar 24) to 95.10, marking an increase of 13.58.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 97.10. This value exceeds the healthy maximum of 70. It has increased from 94.18 (Mar 24) to 97.10, marking an increase of 2.92.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 3.81. This value is within the healthy range. It has increased from 2.66 (Mar 24) to 3.81, marking an increase of 1.15.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.35. This value is below the healthy minimum of 3. It has increased from 1.45 (Mar 24) to 2.35, marking an increase of 0.90.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,267.80. It has increased from 1,198.42 (Mar 24) to 1,267.80, marking an increase of 69.38.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.37. This value is within the healthy range. It has decreased from 1.43 (Mar 24) to 1.37, marking a decrease of 0.06.
- For EV / EBITDA (X), as of Mar 25, the value is 13.12. This value is within the healthy range. It has decreased from 22.10 (Mar 24) to 13.12, marking a decrease of 8.98.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.99. This value is below the healthy minimum of 1. It has decreased from 1.20 (Mar 24) to 0.99, marking a decrease of 0.21.
- For Retention Ratios (%), as of Mar 25, the value is 95.09. This value exceeds the healthy maximum of 70. It has increased from 81.51 (Mar 24) to 95.09, marking an increase of 13.58.
- For Price / BV (X), as of Mar 25, the value is 1.40. This value is within the healthy range. It has decreased from 1.59 (Mar 24) to 1.40, marking a decrease of 0.19.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.99. This value is below the healthy minimum of 1. It has decreased from 1.20 (Mar 24) to 0.99, marking a decrease of 0.21.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.03, marking an increase of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Oriental Aromatics Ltd:
- Net Profit Margin: 3.69%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 9.48% (Industry Average ROCE: 14.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 5.17% (Industry Average ROE: 10.69%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.35
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.71
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 96.7 (Industry average Stock P/E: 56.05)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.53
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 3.69%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Organic - Others | 133 Jehangir Building, 2nd Floor, Mumbai Maharashtra 400001 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Dharmil A Bodani | Chairman & Managing Director |
| Mr. Satish Kumar Ray | Executive Director - Operations |
| Mr. Shyamal A Bodani | Executive Director |
| Mr. Cyrus J Mody | Ind. Non-Executive Director |
| Ms. Sapna Tulsiani | Ind. Non-Executive Director |
| Mr. Deepak R Ramachandra | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Oriental Aromatics Ltd?
Oriental Aromatics Ltd's intrinsic value (as of 28 January 2026) is ₹577.68 which is 105.58% higher the current market price of ₹281.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹947 Cr. market cap, FY2025-2026 high/low of ₹432/250, reserves of ₹645 Cr, and liabilities of ₹1,193 Cr.
What is the Market Cap of Oriental Aromatics Ltd?
The Market Cap of Oriental Aromatics Ltd is 947 Cr..
What is the current Stock Price of Oriental Aromatics Ltd as on 28 January 2026?
The current stock price of Oriental Aromatics Ltd as on 28 January 2026 is ₹281.
What is the High / Low of Oriental Aromatics Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Oriental Aromatics Ltd stocks is ₹432/250.
What is the Stock P/E of Oriental Aromatics Ltd?
The Stock P/E of Oriental Aromatics Ltd is 96.7.
What is the Book Value of Oriental Aromatics Ltd?
The Book Value of Oriental Aromatics Ltd is 197.
What is the Dividend Yield of Oriental Aromatics Ltd?
The Dividend Yield of Oriental Aromatics Ltd is 0.18 %.
What is the ROCE of Oriental Aromatics Ltd?
The ROCE of Oriental Aromatics Ltd is 7.89 %.
What is the ROE of Oriental Aromatics Ltd?
The ROE of Oriental Aromatics Ltd is 5.31 %.
What is the Face Value of Oriental Aromatics Ltd?
The Face Value of Oriental Aromatics Ltd is 5.00.